ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 90 filers reported holding ALLOVIR INC in Q1 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,102,133 | -36.8% | 1,907,969 | 0.0% | 0.20% | -21.7% |
| Q2 2023 | $6,487,095 | -13.7% | 1,907,969 | 0.0% | 0.25% | -23.6% |
| Q1 2023 | $7,517,398 | -23.2% | 1,907,969 | 0.0% | 0.33% | -18.5% |
| Q4 2022 | $9,787,881 | -35.0% | 1,907,969 | 0.0% | 0.40% | -31.5% |
| Q3 2022 | $15,054,000 | +368.8% | 1,907,969 | +131.7% | 0.58% | +374.8% |
| Q2 2022 | $3,211,000 | -42.2% | 823,371 | 0.0% | 0.12% | -28.9% |
| Q1 2022 | $5,558,000 | -47.8% | 823,371 | 0.0% | 0.17% | -28.5% |
| Q4 2021 | $10,654,000 | -49.2% | 823,371 | -1.6% | 0.24% | -33.9% |
| Q3 2021 | $20,973,000 | -32.9% | 836,912 | -47.2% | 0.37% | -21.0% |
| Q2 2021 | $31,270,000 | -31.2% | 1,584,093 | -18.5% | 0.46% | -27.8% |
| Q1 2021 | $45,480,000 | -49.1% | 1,943,587 | -16.4% | 0.64% | -40.8% |
| Q4 2020 | $89,396,000 | +39.3% | 2,325,595 | -0.3% | 1.08% | -8.1% |
| Q3 2020 | $64,168,000 | – | 2,333,390 | – | 1.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |